Ansell launches antiviral condom in Canada

ISELIN, N.J. — Ansell on Tuesday announced the Canada launch of LifeStyles Dual Protect. Dual Protect features patented VivaGel lubricant, an antiviral agent developed by Starpharma.

VivaGel has been proven in laboratory studies to inactivate HIV (human immunodeficiency virus), HSV (herpes simplex virus) and HPV (human papillomavirus), Ansell noted.



"At Ansell, safety and innovation have always been at the forefront of our mission, and we pride ourselves on our ability to identify the needs of our consumers and develop innovative products that not only protect users, but enhance the sexual experience," stated Jeyan Heper, president and general manager, Sexual Wellness Global Business Unit at Ansell. "LifeStyles Dual Protect is a great example of this, and by combining a premium latex condom with Starpharma's patented antiviral VivaGel technology, Ansell is proud to introduce this first-of-its-kind condom to Canadian consumers."



Having been granted a medical device license for the VivaGel condom after an approval process by the Canadian regulatory authority, Health Canada, LifeStyles Dual Protect will become available in Canada via Amazon.ca. Initially launched in Australia, regulatory reviews continue in a number of geographic regions, with further approvals anticipated for this technology in the coming months.